A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

NCT04533529 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

588

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Seltorexant
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC